Nuclear Medicine Begins with a Boa Constrictor
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Focal Spot, Spring 2006
Washington University School of Medicine Digital Commons@Becker Focal Spot Archives Focal Spot Spring 2006 Focal Spot, Spring 2006 Follow this and additional works at: http://digitalcommons.wustl.edu/focal_spot_archives Recommended Citation Focal Spot, Spring 2006, April 2006. Bernard Becker Medical Library Archives. Washington University School of Medicine. This Book is brought to you for free and open access by the Focal Spot at Digital Commons@Becker. It has been accepted for inclusion in Focal Spot Archives by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. SPRING 2006 VOLUME 37, NUMBER 1 *eiN* i*^ MALLINCKRC RADIOLO AJIVERSITY *\ irtual Colonoscopy: a Lifesaving Technology ^.IIMi.|j|IUII'jd-H..l.i.|i|.llJ.lii|.|.M.; 3 2201 20C n « ■ m "■ ■ r. -1 -1 NTENTS FOCAL SPOT SPRING 2006 VOLUME 37, NUMBER 1 MIR: 75 YEARS OF RADIOLOGY EXPERIENCE In the early 1900s, radiology was considered by most medical practitioners as nothing more than photography. In this 75th year of Mallinckrodt Institute's existence, the first of a three-part series of articles will chronicle the rapid advancement of radiol- ogy at Washington University and the emergence of MIR as a world leader in the field of radiology. THE METABOLISM OF THE DIABETIC HEART More diabetic patients die from cardiovascular disease than from any other cause. Researchers in the Institute's Cardiovascular Imaging Laboratory are finding that the heart's metabolism may be one of the primary mechanisms by which diseases such as diabetes have a detrimental effect on heart function. VIRTUAL C0L0N0SC0PY: A LIFESAVING TECHNOLOGY More than 55,000 Americans die each year from cancers of the colon and rectum. -
HISTORY Nuclear Medicine Begins with a Boa Constrictor
HISTORY Nuclear Medicine Begins with a Boa Constrictor Marshal! Brucer J Nucl Med 19: 581-598, 1978 In the beginning, a boa constrictor defecated in and then analyzed the insoluble precipitate. Just as London and the subsequent development of nuclear he suspected, it was almost pure (90.16%) uric medicine was inevitable. It took a little time, but the acid. As a thorough scientist he also determined the 139-yr chain of cause and effect that followed was "proportional number" of 37.5 for urea. ("Propor inexorable (7). tional" or "equivalent" weight was the current termi One June week in 1815 an exotic animal exhibi nology for what we now call "atomic weight.") This tion was held on the Strand in London. A young 37.5 would be used by Friedrich Woehler in his "animal chemist" named William Prout (we would famous 1828 paper on the synthesis of urea. Thus now call him a clinical pathologist) attended this Prout, already the father of clinical pathology, be scientific event of the year. While he was viewing a came the grandfather of organic chemistry. boa constrictor recently captured in South America, [Prout was also the first man to use iodine (2 yr the animal defecated and Prout was amazed by what after its discovery in 1814) in the treatment of thy he saw. The physiological incident was common roid goiter. He considered his greatest success the place, but he was the only person alive who could discovery of muriatic acid, inorganic HC1, in human recognize the material. Just a year earlier he had gastric juice. -
Uses of Isotopic Neutron Sources in Elemental Analysis Applications
EG0600081 3rd Conference on Nuclear & Particle Physics (NUPPAC 01) 20 - 24 Oct., 2001 Cairo, Egypt USES OF ISOTOPIC NEUTRON SOURCES IN ELEMENTAL ANALYSIS APPLICATIONS A. M. Hassan Department of Reactor Physics Reactors Division, Nuclear Research Centre, Atomic Energy Authority. Cairo-Egypt. ABSTRACT The extensive development and applications on the uses of isotopic neutron in the field of elemental analysis of complex samples are largely occurred within the past 30 years. Such sources are used extensively to measure instantaneously, simultaneously and nondestruclively, the major, minor and trace elements in different materials. The low residual activity, bulk sample analysis and high accuracy for short lived elements are improved. Also, the portable isotopic neutron sources, offer a wide range of industrial and field applications. In this talk, a review on the theoretical basis and design considerations of different facilities using several isotopic neutron sources for elemental analysis of different materials is given. INTRODUCTION In principle there are two ways to use neutrons for elemental and isotopic abundance analysis in samples. One is the neutron activation analysis which we call it the "off-line" where the neutron - induced radioactivity is observed after the end of irradiation. The other one we call it the "on-line" where the capture gamma-rays is observed during the neutron bombardment. Actually, the sequence of events occurring during the most common type of nuclear reaction used in this analysis namely the neutron capture or (n, gamma) reaction, is well known for the people working in this field. The neutron interacts with the target nucleus via a non-elastic collision, a compound nucleus forms in an excited state. -
Radioiodine Therapy in Differentiated Thyroid Cancer – a Matter of Controversy – PRO Radioiodine
Journal of Nuclear Medicine, published on May 10, 2018 as doi:10.2967/jnumed.117.191338 Radioiodine therapy in differentiated thyroid cancer – a matter of controversy – PRO Radioiodine Matthias Schmidt, Rainer Görges, Alexander Drzezga, Markus Dietlein Address for correspondence: Prof. Dr. Matthias Schmidt Department of Nuclear Medicine, University Hospital of Cologne Kerpener Str. 62, D – 50937 Koeln (Cologne), Germany P.: +492214785024, F.: +492214786777, E-Mail:<[email protected]> Abstract: Radioiodine therapy is a matter of controversy as different opinions exist towards its use in patients with differentiated thyroid carcinoma. The following article sheds light on different opinions and explains why the authors advocate the use of radioiodine therapy not only in high- risk patients. In comparison to other malignancies differentiated thyroid carcinoma has a different tumor biology due to its usually slow growth pattern. Radioiodine therapy was first used about 75 years ago and provided cure at a time when prospective randomized controlled trials were to be developed. Large patient cohorts and usually at least a decade of clinical follow-up are needed to demonstrate a benefit of radioiodine therapy. Thus, many factors define an individual treatment decision, especially in low risk patients including tumor stage, extent of surgery, tumor biology, clinical and imaging data, life expectancy and patients preferences. Learning Objectives: The reader should (1) know that radioiodine therapy was first introduced about 75 years ago; (2) describe special features of thyroid carcinoma tumor biology in comparison to other malignancies; (3) be able to explain which retrospective studies are needed to favorably value the clinical usefulness of radioiodine therapy; (4) find arguments for and against the use of radioiodine in different tumor stages. -
H*(10) Y Fluencias En Un Irradiador De Neutrones Con Una Fuente De Ra-Be
ISSSD 2020 ONLINE _________________________________________________________________________________ H*(10) y fluencias en un irradiador de neutrones con una fuente de 226Ra-Be Bedher O. Vega-Cabrera1,*, Héctor René Vega-Carrillo2, Víctor M. Viera Castillo1, César J. Guevara Pillaca1, Patrizia E., Pereyra Anaya1 María E. López Herrera1, Daniel F. Palacios Fernández1 1Pontificia Universidad Católica del Perú, Sección de Física. Av. Universitaria 1801, Apartado 1761, Lima – Perú. 2Universidad Autónoma de Zacatecas, Unidad Académica de Estudios Nucleares, C. Ciprés 10, Fracc. La Peñuela, 98068 Zacatecas, Zac. México. * E-mail: [email protected] Resumen Un irradiador de neutrones es un moderador con una fuente isotópica que es usado para enseñanza, entrenamiento y actividades de investigación. Normalmente, el moderador tiene puertos de irradiación radial y/o axial. Con el fin de utilizar el irradiador de neutrones de forma segura y óptima, deben conocerse los niveles de dosis y el espectro de la fluencia de neutrones. En este trabajo se utilizaron métodos Monte Carlo para estimar las fluencias de neutrones en tres rangos de energías: térmicos, epitérmicos y rápidos en siete puertos de un irradiador de neutrones con una fuente 226Ra-Be. El irradiador revestido de plomo contiene parafina wax como medio moderador de neutrones y sus puertos están asignados a diferentes distancias de la fuente de neutrones. El equivalente de dosis ambiental, debido a los neutrones, se estimó a 100 cm lateralmente y a 10 cm por encima del irradiador de neutrones. -
Regional Oral History Office University of California the Bancroft Library Berkeley, California
Regional Oral History Office University of California The Bancroft Library Berkeley, California University of California Source of Community Leaders Series Anne deGruchy Low-Beer Dettner A WOMAN'S PLACE IN SCIENCE AND PUBLIC AFFAIRS: 1932- 1973 With Introductions by Helene Maxwell Brewer and Lawrence Kramer Interviews Conducted by Sally Hughes and Gabrielle Morris in 1994 and 1995 Copyright @ 1996 by The Regents of the University of California Since 1954 the Regional Oral History Office has been interviewing leading participants in or well-placed witnesses to major events in the development of Northern California, the West, and the Nation. Oral history is a modern research technique involving an interviewee and an informed interviewer in spontaneous conversation. The taped record is transcribed, lightly edited for continuity and clarity, and reviewed by the interviewee. The resulting manuscript is typed in final form, indexed, bound with photographs and illustrative materials, and .placed in The Bancroft Library at the University of California, Berkeley, and other research collections for scholarly use. Because it is primary material, oral history is not intended to present the final, verified, or complete narrative of events. It is a spoken account, offered by the interviewee in response to questioning, and as such it is reflective, partisan, deeply involved, and irreplaceable. All uses of this manuscript are covered by a legal agreement between The Regents of the University of California and Anne deGruchy Dettner dated April 20, 1995. The manuscript is thereby made available for research purposes. All literary rights in the manuscript, including the right to publish, are reserved to The Bancroft Library of the University of California, Berkeley. -
Discoverers of Thyroid Landmarks
Clark T. Sawin, MD July, 2002 Discoverers of Thyroid Landmarks Jean-François Coindet Caleb H. Parry Robert J. Graves Adolphe Chatin William W. Gull George R. Murray Edward C. Kendall David Marine Charles R. Harington Saul Hertz Edwin B. Astwood Jean-François Coindet (1774-1834) and the Treatment of Goiter with Iodine Jean-François Coindet was the first to realize that iodine could be a successful treatment for goiter. Iodine had just been discovered a few years before the publication in 1820 of his lecture that startled his Genevan colleagues. For some centuries, seaweed and burnt sea-sponge had been well-used folk medicines to treat goiter. Coindet suspected that, because of the way that iodine had been discovered as a residue of extracted seaweed, iodine itself might be the active ingredient in burnt sponge that affected goiter. He tried it and it worked. Coindet was a native Genevan who went to Edinburgh, then a mecca for medical training, for his MD and returned to Geneva in 1799 to begin his medical practice. He was quite successful and even at one point represented Geneva in the Swiss confederation. Goiter was particularly well-known in many areas of Switzerland although the cause was obscure. When Coindet thought that iodine might be good for goiter, he had a sample of sea sponge tested just to be sure it contained iodine: it did. So he abandoned the use of natural products and used iodine directly. His paper was picked up all around Europe, including an English translation in a London medical journal, and the treatment was tried equally widely. -
Radiocarbon Revolution Chris Turney Applauds a Book on Carbon-14 and Its Key Applications
JAMES KING-HOLMES/SPL JAMES A human femur, thought to be from medieval times, being sampled for carbon dating. GEOSCIENCE Radiocarbon revolution Chris Turney applauds a book on carbon-14 and its key applications. t is nearly 80 years since the discovery — whose discoveries the carefully gathered sample and found that of carbon-14, a radioactive isotope of made possible the it was measurably radioactive. The story of the sixth element. Because its decay can theory, practice and 14C thus began with a dose of high drama. Ibe used to track the passage of time, radio- further findings we Originally expected to have a half-life of carbon has made myriad contributions now take for granted. just minutes or hours, this heavy form of car- across the Earth, environmental, biological There’s enough to sat- bon was considered a low research priority. and archaeological sciences. In the wonder- isfy the most in satiable But Kamen and Ruben’s efforts proved that fully engaging Hot Carbon, oceanographer informavore. it would be stable over millennia, opening up John Marra takes this story much further, Hot Carbon starts a breathtaking number of research avenues exploring not just the science, but why we with the extraordi- (its half-life of 5,730 years was determined should care about it. nary story of chemist Hot Carbon: some years later). Kamen never received the Carbon-14 and Radiocarbon is scarce in nature, formed in Martin Kamen, born a Revolution in credit he deserved, becoming a victim of the the upper atmosphere through the interaction in Canada to Russian Science US anti-communist fervour of the 1940s and of cosmic rays with nitrogen. -
Radiation Safety Training
Radiation Safety Training …it concerns your health! 8/30/2006 Charlie Freeman, RSO Slide #1 SUNY Genseseo Atomic Structure Nucleus Orbiting Electrons – Contains Protons and – “Cloud” of orbiting Neutrons electrons surrounds nucleus – Cloud is relatively large – Small Size (~1E-14 m) (~1E-10 m) – Relatively Large Mass – Low mass – Extremely Large Density – Small amount of Stored – Large amount of Stored Energy Energy – Responsible for Chemical Bonds 8/30/2006 Charlie Freeman, RSO Slide #2 SUNY Genseseo Nomenclature • Element Designation A – “X” = Element Symbol X – “Z” = # protons in nucleus Z • “Atomic #” (each element has a unique Z, see periodic For Example table) 16 – “N” = # neutrons 8 O = O-16 = Oxygen 16 – Atomic mass # = “A” 17 • A = Z + N 8 O = O-17 = Oxygen 17 • Isotope: same Z, different N 197 and A 79 Au = Au-197 = Gold 197 8/30/2006 Charlie Freeman, RSO Slide #3 SUNY Genseseo Example: P-32 • 15 protons 32 • 17 neutrons P • A = 32 15 • Z =15 8/30/2006 Charlie Freeman, RSO Slide #4 SUNY Genseseo Ion • In an electrically neutral atom or molecule, the number of electrons equals the number of protons • Any atom or molecule with an imbalance in electrical charge is called an ion • Ions are chemically unstable, and will seek electrical neutrality by reacting with other atoms or molecules. 8/30/2006 Charlie Freeman, RSO Slide #5 SUNY Genseseo Radioactivity • Definition: A collection of unstable atoms that undergo spontaneous transformation that result in new elements. The degree of radioactivity is given by the number of decays that occur per unit time (decays per minute) • Units of measure: – Dpm, dps – Curie (Ci): 1 Ci = 3.7E10 dps – Bequerel (Bq): 1 Bq = 1dps 8/30/2006 Charlie Freeman, RSO Slide #6 SUNY Genseseo Half-Life & Decay Law • The activity of a sample of radioactive 225 200 atoms decreases over 175 150 time 125 100 75 Activity (Curies) • Half-life: how long it 50 25 takes for activity of 0 0 1 2 3 4 5 6 7 sample to decrease by Time (hours) a factor of ½. -
(IKB): Absolute Dating Methods in Archaeology and the Basis Of
14C u okolišu 14C v okolju 14C in environment Ines KRAJCAR BRONIĆ i Jadranka BAREŠIĆ [email protected] IJS, Ljubljana, 9.12.2015. • 14C metoda – uvod, ciklus ugljika, produkcija 14C • Raspodjela ugljika u prirodi (atmosfera) • Određivanje starosti • Veličine i jedinice • Procjena doze • Mjerne tehnike određivanja 14C • Monitoring 14C u okolici NE • Monitoring u okolici NEK 2 Carbon isotopes 12C 13C 14C 98.89 % 1.11 % 10-10 % p = n = 6 n = 7 n = 8 T = 5730 y 1/2 3 U atmosferi - uglavnom kao CO2, 0,03 (0,04)% vol. - važna uloga za održavanje života na Zemlji - koriste biljke za proces fotosinteze ATMOSFERA 580 GtC (18.st) - 750 + (danas) 100 pMC (do 200 pMC u 20.st) Vraća se u -6,5‰ do -8‰ atmosferu disanjem biljaka i životinja, raspadanjem BIOSFERA vegetacija 600 GtC FOSILNA GORIVA biljnog i životinjskog 100 pMC Površinski ocean 10-20000 GtC tkiva, spaljivanjem (-25 ± 5)‰ 800 - 1000 GtC 0 pMC organskog 95 pMC (-25 ± 5)‰ (0 ± 2)‰ materijala, tlo 1600 GtC oslobađanjem iz <100 pMC (-25 ± 5)‰ tople morske vode i SEDIMENTNE STIJENE vulkanskim 66 - 100 x 109 GtC erupcijama. Duboki ocean 0 pMC 38-40000 GtC (0 ± 2)‰ <100 pMC 0 ‰ CO se otapa u morskoj vodi (veća 2 Izgaranjem fosilnih goriva oslobađa topivost u hladnijoj vodi), a i u vodi 4 se ugljik koji je milijunima godina koja prolazi kroz tlo, stvarajući bio spremljen u litosferi. ugljičnu kiselinu, koja može otapati vapnenačke stijene. Discovery of 14C Obituary Martin Kamen Scientist, co-discoverer of the isotope that gave archaeology carbon-dating, and innocent victim of America's Communist witchhunts (Pearce Wright , The Guardian, Monday 9 September 2002) The American scientist Professor Martin Kamen was the co-discoverer of the radioactive isotope carbon-14. -
We Commemorate Today the 80Th Anniversary of the First Therapeutic Use of Radioactive Sodium Iodide (I-130) Given to a Young Woman with Graves’ Disease by Dr
We commemorate today the 80th Anniversary of the first therapeutic use of radioactive sodium iodide (I-130) given to a young woman with Graves’ Disease by Dr. Saul Hertz in 1941. The title banner is a clip from the table made by the legendary physician who conceived the idea, studied iodine kinetics on the animal model, and finally took it to the clinic by literally running a vial with radioactive iodine (RAI) from the cyclotron facility at the Massachusetts Institute of Technology (MIT) to the Thyroid Unit at the Massachusetts General Hospital (MGH) where he was the Clinical Director. The first patient, a young woman suffering from Graves’ disease, was waiting for him to bring the novel radioactive medicine for her experimental treatment! This remarkable story would not have happened if not for a eureka moment that occurred on November 11th, 1936 when Dr. Hertz sat listening to a lecture at MIT on how elements can be made radioactive. He was taking a break from clinical work and the animal research on thyroid iodine metabolism that required tedious measurements of tiny amounts of stable iodine. Understandably, he could hardly wait till the end of the lecture to ask the burning question – can iodine be made radioactive? But the answer was not immediately available and the lector, Professor Compton, wrote back to Dr. Hertz on December 15th, 1936 that while radioactive iodine is not well defined yet, it can be done! But as it turns out, to get enough of it for animal experiments and possibly therapeutic trials, it would require a cyclotron! A novelty at the time, the only one available in the U.S.A. -
Activation Analysis - Nuclear Chemical Research * Radiochemical Separations
DEPARTMENT OF CHEMISTRY UNIVERSITY OF MICHIGAN ANN ARBOR, MICHIGAN . ACTIVATION ANALYSIS - NUCLEAR CHEMICAL RESEARCH * RADIOCHEMICAL SEPARATIONS PROGRESS REPORT 9 November 1, 1960 Supported by DEPARTMENT OF CHEMISTRY MICHIGAN MEMORIAL-PHOENIX PROJECT UNITED ST ATES ATOMIC ENERGY COMMISSION PROJECT NO. 7, CONTRACT NO. AT (11-1)-70 DEPARTMENT OF CHEMISTRY U N I V E R S I T Y O F M I C H I G A N Ann Arbor, Michigan PROGRESS REPORT 9 November 1959 - October 1960 ACTIVATION ANALYSIS NUCLEAR CHEMICAL RESEARCH RADIOCHEMICAL SEPARATIONS Edited by R. S. Maddock and W. W. Meinke, (Project Director) November 1, 1960 Supported by Department of Chemistry Michigan-Memorial Phoenix Project Project No. 7 Contract No. AT(ll-1)-70 U. S. Atomic Energy Commission The following is a report of the work completed on Project No. 7, Contract No. AT(ll-1)-70 during the year of November 1, 1959 to October 31, 1960. Previous progress reports are listed below: Progress Report 1 Novemb er 1952 Progress Report 2 November 1953 Progress Report 3 November 1954 Progress Report 4 (AECU-3116) November 1955 Progress Report 5 (AECU-3375) November 1956 Progress Report 6 (AEcU-3641) November 1957 Progress Report 7 (AEcu.-3887) November 1958 Progress Report 8 (AECU-4438) November 1959 ii FOREWARD A word is perhaps in order about the philosophy of these progress reports which are issued yearly from our laboratories. In any research program a large amount of information is obtained and techniques developed which never find their way into the literature. This includes the "negative results" which are so disappointing and unspectacular but which can often save others considerable work.